SULT2B1 and esophageal squamous cell carcinoma: SULT2B1 can inhibit the proliferation of esophageal squamous cell carcinoma (ESCC) cells, and the hypermethylation of its promoter can promote the progression of esophageal tumor by downregulating PER1 (Figure 2a) [12].